Merck | MRK - Selling And Administration Expenses



Merck reported EUR1.48B in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Adidas EUR 712M 1.9B Jun/2025
Adyen EUR 353.68M 120.12M Dec/2024
Akzo Nobel EUR 826M 29M Jun/2025
Alcon AG USD 870M 57M Jun/2025
Amadeus IT EUR 497.5M 206.6M Mar/2025
Amarin USD 36.57M 397K Mar/2025
AstraZeneca USD 5.01B 1.42B Jun/2025
BASF EUR 2.58B 67M Jun/2025
Bayer EUR 3.55B 162M Jun/2025
Beiersdorf EUR 322M 1.68B Jun/2025
Covestro EUR 449M 28M Jun/2025
Danone EUR 4.87B 141M Jun/2025
Fresenius EUR 740M 97M Jun/2025
Fresenius Medical Care EUR 792M 41M Jun/2025
Galapagos EUR 30.67M 13.12M Jun/2025
Genmab DKK 144M 18M Jun/2025
Givaudan CHF 294.5M 229.5M Jun/2024
GlaxoSmithKline GBP 2.14B 80M Jun/2025
GRIFOLS EUR 282.76M 41.9M Jun/2025
Henkel EUR 3.45B 213M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
Infineon EUR 410M 34M Jun/2025
Linde USD 870M 56M Jun/2025
Merck EUR 1.48B 9M Jun/2025
Novartis USD 3.44B 384M Jun/2025
Philips EUR 1.24B 9M Jun/2025
Roche Holding CHF 3.61B 381M Dec/2024
Sanofi EUR 2.63B 408M Jun/2025
UCB EUR 1.29B 221M Dec/2024